AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 99 filers reported holding AVROBIO INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $376,000 | -33.1% | 97,597 | -3.1% | 0.01% | -38.5% |
| Q3 2021 | $562,000 | -36.4% | 100,705 | +1.3% | 0.01% | -31.6% |
| Q2 2021 | $884,000 | -32.8% | 99,413 | -4.0% | 0.02% | -26.9% |
| Q1 2021 | $1,315,000 | -48.7% | 103,591 | -43.7% | 0.03% | -55.2% |
| Q4 2020 | $2,565,000 | +56.2% | 184,001 | +45.9% | 0.06% | +23.4% |
| Q3 2020 | $1,642,000 | -26.5% | 126,103 | -1.5% | 0.05% | -27.7% |
| Q2 2020 | $2,234,000 | +17.4% | 128,018 | +4.7% | 0.06% | -7.1% |
| Q1 2020 | $1,903,000 | -42.3% | 122,310 | -25.3% | 0.07% | -13.6% |
| Q4 2019 | $3,296,000 | – | 163,745 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 4,520,863 | $5,968,000 | 0.76% |
| Aisling Capital Management LP | 1,009,779 | $1,333,000 | 0.72% |
| MPM BioImpact LLC | 647,918 | $855,000 | 0.23% |
| GMT CAPITAL CORP | 2,594,914 | $3,425,000 | 0.22% |
| New Leaf Venture Partners, L.L.C. | 315,550 | $417,000 | 0.21% |
| GSA CAPITAL PARTNERS LLP | 338,422 | $447,000 | 0.06% |
| Penn Mutual Asset Management, LLC | 37,306 | $49,000 | 0.06% |
| Eversept Partners, LP | 295,369 | $389,887 | 0.03% |
| XTX Topco Ltd | 23,289 | $31,000 | 0.01% |
| Colonial River Wealth Management, LLC | 17,636 | $23,000 | 0.01% |